[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350102-105":3,"doc-detail-350102-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","map3k1-a-multifunctional-kinase-at-the-crossroads-of-cancer-progression-and-tumor-suppression","MAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression","","Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) has dual enzymatic roles, combining kinase and E3 ubiquitin ligase activities to regulate proliferation, survival, apoptosis, DNA damage response, and immune modulation. Genomic and mechanistic findings show context-dependent, paradoxical behavior as both an oncogene and a tumor suppressor. Its multidomain architecture integrates JNK, p38 MAPK, ERK, and NF-κB pathways, with caspase-3 cleavage at Asp878 promoting pro-apoptotic signaling. Across multiple cancer types, MAP3K1 alterations occur at \u003C1–14% frequency, with tissue-specific patterns and prognostic differences, and they may predict responses to MEK and PI3K inhibitors. Remaining gaps involve E3 ligase substrates, determinants of context-specific activity, and therapeutic strategies to enable clinical translation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/map3k1-a-multifunctional-kinase-at-the-crossroads-of-cancer-progression-and-tumor-suppression/350102/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/map3k1-a-multifunctional-kinase-at-the-crossroads-of-cancer-progression-and-tumor-suppression/350102.png","ImageObject",300,407,{"name":42,"@type":43},"Maya Linwood","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What dual functions does MAP3K1 perform in cells?","Question",{"text":63,"@type":64},"MAP3K1 acts as both a kinase and an E3 ubiquitin ligase. These coordinated activities regulate proliferation, survival, apoptosis, DNA damage response, and immune modulation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MAP3K1’s domain architecture connect it to major signaling pathways?",{"text":68,"@type":64},"Its N-terminal RING and PHD domains support E3 ligase activity, a TOG domain links to microtubule dynamics, and a C-terminal kinase domain enables kinase signaling. Together they integrate JNK, p38 MAPK, ERK, and NF-κB pathways.",{"name":70,"@type":61,"acceptedAnswer":71},"How are MAP3K1 alterations distributed across cancer types, and what clinical implications are suggested?",{"text":72,"@type":64},"Genomic analyses across more than 35 cancer types show alteration frequencies of \u003C1–14%, with tissue-specific patterns such as loss-of-function mutations in hormone receptor-positive breast cancer and gain-of-function in melanoma activating ERK signaling. The document also suggests MAP3K1 mutations may predict response to MEK and PI3K inhibitors, with mutant tumors showing higher MEK inhibitor response.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350102,1790683756,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d",8,"Review  \nMAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression  \nLelisse T. Umeta 1,2, * and Amarnath Natarajan 1,2, *  \nAcademic Editor: Alexander E. Kalyuzhny  \nReceived: 28 February 2026  \nRevised: 25 March 2026  \nAccepted: 27 March 2026  \nPublished: 28 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE 68198, USA  \n2 Division of Pharmaceutical Sciences, James L. Winkle, College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA  \n* [Correspondence: umetalt@ucmail.uc.edu](Correspondence: umetalt@ucmail.uc.edu) (L.T.U.); [nataraah@ucmail.uc.edu](nataraah@ucmail.uc.edu) (A.N.)  \nAbstract  \nMitogen-activated protein kinase kinase kinase 1 (MAP3K1) possesses dual enzymatic functions, i.e., kinase and E3 ubiquitin ligase activities, orchestrating proliferation, survival, apoptosis, DNA damage response, and immune modulation. Recent genomic and mechanistic studies have revealed MAP3K1’s paradoxical, context-dependent roles as both an oncogene and a tumor suppressor. We discuss MAP3K1’s multidomain architecture, featuring an N-terminal RING and PHD domain (E3 ligase activity), a TOG domain (microtubule dynamics), and a C-terminal kinase domain, enabling the integration ofc-jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK), and nuclear factor kappa B (NF-κB) signaling pathways. MAP3K1 functions as a molecular switch balancing survival and apoptosis, with caspase-3 cleavage at Asp878 activating pro-apoptotic JNK/p38 signaling. Genomic analyses across >35 cancer types reveal MAP3K1 alterations at frequencies of \u003C1–14%, highest in breast and endometrial cancers. These alterations show tissue specificity: lossof-function mutations predominate in hormone receptor-positive breast cancer with a favorable prognosis, whereas gain-of-function mutations in melanoma activate oncogenic ERK signaling. MAP3K1 mutations predict response to mitogen-activated protein kinasekinase (MEK) and phosphoinositide 3-kinase (PI3K) inhibitors, with mutant cancers showing higher MEK inhibitor response than wild-type tumors. Despite substantial progress, critical gaps remain regarding MAP3K1’s E3 ligase substrates, context-dependent activity determinants, and therapeutic strategies. Addressing these through inhibitor development, biomarker validation, and mechanistic studies will accelerate potential clinical translation of MAP3K1 biology.  \nKeywords: MAP3K1; kinase; E3 ligase; signaling; oncogene; tumor suppressor  \n1. Introduction  \nMitogen-activated protein kinase (MAPK) signaling is an evolutionarily conserved signaling network that plays critical roles in both normal physiology and disease states [1–3] . The canonical MAPK pathway comprises a 3-step cascade of serine/threonine and tyrosine kinases that are activated by diverse stimuli, triggering phosphorylation cascades involving combinations of 24 MAP3Ks, 7 MAP2Ks, and 14 MAPKs to regulate cell proliferation, survival, motility, stress response, and apoptosis [1] . Consequently, dysregulation of MAPK pathway proteins rewires signaling cascades to facilitate cancer initiation and progression. This made proteins in the MAPK signaling network attractive therapeutic targets for cancer,  \nwith 10 FDA-approved monotherapies, four combination therapies targeting components of MAPK signaling, and several more under clinical investigation [2–5] . However, the efficacy of these drugs has been challenged by emerging resistance arising from crosstalk among parallel pathways, feedback loops, and feedforward circuits [6–8] .  \nAmong MAPK cascade components, Mitogen-Activated Protein Kinase Kinase Kinase (MAP3K1, also known as MEKK1) stands o","cbCaid9eKMzMKH20","https://ap.wps.com/l/cbCaid9eKMzMKH20","pdf",3128565,37,"English","# Abstract\n# Keywords\n# Introduction\n## MAPK signaling and therapeutic relevance\n## MAP3K1 structure and enzymatic functions\n## MAP3K1 activation pathways and downstream signaling\n## Context-dependent roles in cancer cell fate","[{\"question\":\"What dual functions does MAP3K1 perform in cells?\",\"answer\":\"MAP3K1 acts as both a kinase and an E3 ubiquitin ligase. These coordinated activities regulate proliferation, survival, apoptosis, DNA damage response, and immune modulation.\"},{\"question\":\"How does MAP3K1’s domain architecture connect it to major signaling pathways?\",\"answer\":\"Its N-terminal RING and PHD domains support E3 ligase activity, a TOG domain links to microtubule dynamics, and a C-terminal kinase domain enables kinase signaling. Together they integrate JNK, p38 MAPK, ERK, and NF-κB pathways.\"},{\"question\":\"How are MAP3K1 alterations distributed across cancer types, and what clinical implications are suggested?\",\"answer\":\"Genomic analyses across more than 35 cancer types show alteration frequencies of \\u003c1–14%, with tissue-specific patterns such as loss-of-function mutations in hormone receptor-positive breast cancer and gain-of-function in melanoma activating ERK signaling. The document also suggests MAP3K1 mutations may predict response to MEK and PI3K inhibitors, with mutant tumors showing higher MEK inhibitor response.\"}]","MAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression | PDF",1790087197,93,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a1c147062d281dd7c4fb4b9ffb70ac1.webp",983,1390,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e91b6dbecd53c07060d990457f619700.webp",982,1388,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3fbd050919196db77ba80e1dcc4b3ca.webp",981,1387,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31e082c4e34dc3648f0cacca85528a21.webp",980,1385,{"code":4,"msg":82,"data":117},[118,122,126,130,134,139,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},"Comic",60,"comic",{"id":135,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},6,"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":55,"slug":162},19,"General","general"]